Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Other Non-Current Liabilities: 2017-2018

  • Astria Therapeutics' Other Non-Current Liabilities was N/A to $56,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $56,000, marking a year-over-year change of. This contributed to the annual value of $56,000 for FY2018, which is N/A change from last year.
  • Astria Therapeutics' Other Non-Current Liabilities amounted to $56,000 in Q4 2018, which was down 81.70% from $306,000 recorded in Q2 2017.
  • Astria Therapeutics' Other Non-Current Liabilities' 5-year high stood at $306,000 during Q2 2017, with a 5-year trough of $56,000 in Q4 2018.
  • Its 2-year average for Other Non-Current Liabilities is $216,667, with a median of $288,000 in 2017.